| Group I No. = 117 | Group II No. = 199 | Test value | p-value | Sig. | |
Hypertension | Negative Positive NA | 36 (30.8%) 81 (69.2%) 0 (%) | 170 (85.4%) 24 (12.1%) 5 (2.5%) | 105.511 | 0.000 | HS |
Comorbidities other than hypertension | Present Absent NA | 39 (33.3%) 78 (66.7%) 0 (0%) | 21 (10.6%) 162 (81.4%) 16 (8 %) | 21.311 | 0.000 | HS |
Type of the surgery performed | MRM BCS SCM NA | 64 (54.7%) 43 (36.8%) 0 (0%) 10 (8.5) | 96 (48.2%) 86 (43.2%) 4 (2.1%) 13 (6.5%) | 5.254 | 0.072 | NS |
Pathology | IDC ILC other | 100 (85.5%) 10 (8.5%) 7 (6%) | 172 (86.5%) 17 (8.5%) 10 (5%) | 5.254 | 0.072 | NS |
Grade | 1 | 0 (0.0%) | 1 (0.5%) | 2.117 | 0.347 | NS |
2 | 98 (83.8%) | 176 (88.4%) | ||||
3 | 19 (16.2%) | 22 (11.1%) | ||||
T stage | <2 cm 2 - 5 cm 5 cm and more NA | 20 (17.1%) 63 (53.9%) 28 (23.9%) 6 (5.1%) | 36 (18.1%) 112 (56.3%) 44 (22.1%) 7 (3.5%) | 7.172 | 0.127 | NS |
N stage | 0 From 1 - 3 LNs More than 3 LNs NA | 24 (20.5%) 41 (35.1%) 44 (37.6%) 8 (6.8%) | 61 (30.7%) 66 (33.2%) 63 (31.6%) 9 (4.5%) | 4.138 | 0.247 | NS |
LVI | Negative Positive NA | 35 (29.9%) 25 (21.4%) 57 (48.7%) | 71 (35.7%) 40 (20.1%) 88 (44.2%) | 0.524 | 0.469 | NS |
Inflammatory manifestations | Negative positive NA | 101 (86.3%) 14 (12%) 2 (1.7%) | 164 (82.4%) 18 (9.1%) 17 (8.5%) | 0.382 | 0.536 | NS |
Extracapsular extension | Negative Positive NA | 39 (33.3%) 18 (15.4%) 60 (51.3%) | 63 (31.7%) 48 (24.1%) 88 (44.2%) | 2.148 | 0.143 | NS |
Multiplicity | Negative Positive NA | 86 (73.5%) 24 (20.5%) 7 (6%) | 167 (84 %) 21 (10.5%) 11 (5.5%) | 6.137* | 0.013 | S |